Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Diseases

Explore clinical trials studying Gastrointestinal Diseases. Study availability and eligibility vary by location and protocol.

18,017 public trials 3,510 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Diseases trial results

Recruiting

PRE-ISPY Phase I/II Oncology Platform Program

NCT05868226

Conditions
Adenocarcinoma, Adenocarcinoma of Colon, Breast Diseases, +51 more
Locations
  • The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
  • UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital New Lenox, Illinois, United States
View Trial Details
Recruiting

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

NCT05080673

Conditions
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Colonic Diseases, +12 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
View all 493 locations
View Trial Details
Recruiting

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

NCT07070232

Conditions
Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, Bronchogenic, +25 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of California San Francisco San Francisco, California, United States
  • Hartford Healthcare Hartford, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
View all 76 locations
View Trial Details
Recruiting

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

NCT07216105

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +48 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
  • Thomas Jefferson University, Sidney Kimmel Cancer Center Philadelphia, Pennsylvania, United States
  • M. D. Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

NCT07292298

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Rochester Medical Center Rochester, New York, United States
  • Oregon Health and Sciences University Portland, Oregon, United States
View Trial Details
Recruiting

Family Communications After Genetic Testing

NCT07143487

Conditions
Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +25 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
View all 319 locations
View Trial Details
Recruiting

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

NCT05319730

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations
  • University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 4927) Tucson, Arizona, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 4905) Los Angeles, California, United States
  • Hematology-Oncology Associates of Central NY, P.C. ( Site 4925) East Syracuse, New York, United States
  • Columbia University Irving Medical Center-CUIMC Herbert Irving Comprehensive Cancer Center Clinical ( Site 4907) New York, United States
View all 58 locations
View Trial Details
Recruiting

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

NCT05174169

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +9 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
View all 1077 locations
View Trial Details
Recruiting

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

NCT06469944

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +10 more
Locations
  • University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 6927) Tucson, Arizona, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 6905) Los Angeles, California, United States
  • Norton Hospital-Norton Cancer Institute - Downtown ( Site 6900) Louisville, Kentucky, United States
  • The Cancer and Hematology Centers ( Site 6912) Grand Rapids, Michigan, United States
View all 50 locations
View Trial Details

Related conditions